Pillstats
Rx only · Tablet · Oral

Nefazodone Hydrochloride

Nefazodone Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)1098666
US makers2 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.380$0.759$1.14$1.52Feb 2025Feb 2026Apr 2026
$1.290
Latest avg · Apr 22, 2026
+2%
Since Feb 19, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1292583875162025 Q12025 Q22025 Q32025 Q42026 Q1
326
Rx · 2026 Q1
24K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown5SUPPLYING
Bryant Ranch Prepackrepackager4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.